Showing results (461-470 of 1,391) with videos related to
Sort By:
Pageof 140
Current Drug Targets|April 29, 2005
Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathwaysP Tagliaferri, P Tassone, S Blotta, et al.Plos One|July 11, 2013
Torsin A Localization in the Mouse Cerebellar Synaptic CircuitryFrancesca Puglisi, Valentina Vanni, Giulia Ponterio, et al.Journal of Ovarian Research|February 8, 2013
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?Nicoletta Staropoli, Domenico Ciliberto, Cirino Botta, et al.Clinical Genetics|June 22, 2013
A family with two female siblings with compound heterozygous FMR1 premutation allelesK Basuta, R Lozano, A Schneider, et al.American Journal of Medical Genetics|September 20, 2000
Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNAF Tassone, R J Hagerman, D Z Loesch, et al.Molecular Therapy. Nucleic Acids|November 29, 2019
An Anti-BCMA RNA Aptamer for miRNA Intracellular DeliverySilvia Catuogno, Maria Teresa Di Martino, Silvia Nuzzo, et al.Neuropharmacology|July 8, 2008
Distinct roles of group I mGlu receptors in striatal functionP Bonsi, P Platania, G Martella, et al.Calcified Tissue International|April 22, 2009
May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?Laura Gianotti, Francesco Tassone, Anna Pia, et al.Genetic Testing and Molecular Biomarkers|October 9, 2009
High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction techniqueJennifer Yuhas, Paulina Walichiewicz, Ruiqin Pan, et al.Clinical Immunology (Orlando, Fla.)|January 7, 2012
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivoLeonard Moise, Chang Song, William D Martin, et al.Pageof 140